CytoSorbents Corporation (CTSO)

[orangecat]

How was it a bust? Even before the refresh one trial started they stated one of the objective was to identify the types of procedures that results in high plasma hemoglobin levels. They were aware that some did and some did not. They also repeated this line of thought in each presentstion after. You seem to be down playing an annual US patient population of 100,000 to 150,000 patients? That is 150 million dollars in potential sales for just the cardiac indication, in just the US.